Table 1 Clinical characteristics of aplastic anemia patients with and without infectious episodes
From: Infections in patients with aplastic Anemia in Chiang Mai University
Characteristics | Total | Without IEs | With IEs | p-value |
|---|---|---|---|---|
(N = 67) | (N = 45) (67.2%) | (N = 22) (32.8%) | ||
Age (years); Median (range) | 51 (15–87) | 49 (15–87) | 49 (18–75) | 0.459 |
Male, N (%) | 37 (55.2) | 27 (60.0) | 10 (45.4) | 0.052 |
Severe Aplastic Anemia, N (%) | 42 (62.8) | 27 (57.45) | 21 (72.41) | 0.189 |
CBC at Diagnosis | ||||
Hemoglobin; Median (range) (g/dl) | 7.7 (2.5–12.6) | 7.6 (2.5–12.6) | 7.5 (2.7–12.0) | 0.536 |
White Blood Cells; Median (range) (/mm3) | 2995 (120–8020) | 3070 (1470–5300) | 1870 (70–6900) | 0.287 |
Absolute Neutrophil Count; Median (range) (/mm3) | 984 (120–5500) | 984 (147–2418) | 655 (12–3208) | 0.022 |
Platelet; Median (range) (/mm3) | 14,000 (1000-125,000) | 17,000 (4000-104,000) | 14,000 (1000-125,000) | 0.275 |
Treatment with ATG-CsA | ||||
Received Treatment, N (%) | 25 (37.3) | 14 (31.1) | 11 (50.0) | 0.789 |
Time Period of Treatment; Median (range) (months) | 14.6 (0.8–38.1) | 15.2 (4.1–36.2) | 4.7 (0.8–38.1) | 0.439 |
Response, N (%) | 18 (70.0) | 10 (71.4) | 7 (63.6) | 0.745 |
Treatment with Anabolic Hormone | ||||
Received Treatment, N (%) | 41 (61.2) | 28 (62.2) | 13 (59.1) | 0.545 |
Time Period of Treatment; Median (range) (months) | 10.4 (1.7–104.1) | 12.5 (2.1–50.6) | 10.4 (1.7–104.1) | 0.850 |
Response, N (%) | 38 (92.7) | 27 (96.4) | 11 (84.6) | 0.071 |